Hydromorphone Hydrochloride Injection, Solution
NDC Package 81371-4100-7

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Hydromorphone Hydrochloride injection is a drug for further processing. This formulation utilizes a injection, solution delivery system. Marketed by Bond Pharmacy Inc, this product is identified by NDC 81371-4100.

Identification & Billing

NDC Package Code
81371-4100-7
Package Description
75 mL in 1 BAG
Product Code
81371-4100
11-Digit Billing Format
81371410007
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
75 ML

Clinical Specifications

Proprietary Name
Hydromorphone Hydrochloride
Non-Proprietary Name
Hydromorphone Hydrochloride
Substance Name
Hydromorphone Hydrochloride
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Active Ingredient(s)
HYDROMORPHONE HYDROCHLORIDE 100 mg/mL
DEA Schedule
Schedule II (CII) Substances

Regulatory & Marketing

Labeler Name
Bond Pharmacy Inc
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
05-03-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 81371-4100-7 identifies a specific commercial package of 75 ml in 1 bag of Hydromorphone Hydrochloride (UNFINISHED drug), drug for further processing labeled by Bond Pharmacy Inc. This product is billed per "ML" milliliter and contains an estimated amount of 75 billable units per package. This injection, solution is formulated for use and contains hydromorphone hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bond Pharmacy Inc on May 03, 2021. The current certification is valid through December 31, 2026.

How is this Bond Pharmacy Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 81371410007. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 75 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
81371-4100-7
11-Digit CMS (5-4-2)
81371-4100-07

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.